Literature DB >> 26729038

Obesity in 2015: Advances in managing obesity.

John B Dixon1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26729038     DOI: 10.1038/nrendo.2015.221

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  9 in total

1.  Screening for and management of obesity in adults: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2012-09-04       Impact factor: 25.391

Review 2.  ReShape and Orbera--two gastric balloon devices for weight loss.

Authors: 
Journal:  Med Lett Drugs Ther       Date:  2015-08-31       Impact factor: 1.909

3.  Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

Authors:  Bernard Zinman; Christoph Wanner; John M Lachin; David Fitchett; Erich Bluhmki; Stefan Hantel; Michaela Mattheus; Theresa Devins; Odd Erik Johansen; Hans J Woerle; Uli C Broedl; Silvio E Inzucchi
Journal:  N Engl J Med       Date:  2015-09-17       Impact factor: 91.245

4.  The effect of rate of weight loss on long-term weight management: a randomised controlled trial.

Authors:  Katrina Purcell; Priya Sumithran; Luke A Prendergast; Celestine J Bouniu; Elizabeth Delbridge; Joseph Proietto
Journal:  Lancet Diabetes Endocrinol       Date:  2014-12       Impact factor: 32.069

5.  Efficacy and safety of beloranib for weight loss in obese adults: a randomized controlled trial.

Authors:  D D Kim; J Krishnarajah; S Lillioja; F de Looze; J Marjason; J Proietto; S Shakib; B G A Stuckey; J E Vath; T E Hughes
Journal:  Diabetes Obes Metab       Date:  2015-03-31       Impact factor: 6.577

Review 6.  Management of obesity: improvement of health-care training and systems for prevention and care.

Authors:  William H Dietz; Louise A Baur; Kevin Hall; Rebecca M Puhl; Elsie M Taveras; Ricardo Uauy; Peter Kopelman
Journal:  Lancet       Date:  2015-02-19       Impact factor: 79.321

7.  Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial.

Authors:  Geltrude Mingrone; Simona Panunzi; Andrea De Gaetano; Caterina Guidone; Amerigo Iaconelli; Giuseppe Nanni; Marco Castagneto; Stefan Bornstein; Francesco Rubino
Journal:  Lancet       Date:  2015-09-05       Impact factor: 79.321

8.  A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.

Authors:  Xavier Pi-Sunyer; Arne Astrup; Ken Fujioka; Frank Greenway; Alfredo Halpern; Michel Krempf; David C W Lau; Carel W le Roux; Rafael Violante Ortiz; Christine Bjørn Jensen; John P H Wilding
Journal:  N Engl J Med       Date:  2015-07-02       Impact factor: 91.245

Review 9.  Effects of anti-obesity drugs, diet, and exercise on weight-loss maintenance after a very-low-calorie diet or low-calorie diet: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Kari Johansson; Martin Neovius; Erik Hemmingsson
Journal:  Am J Clin Nutr       Date:  2013-10-30       Impact factor: 7.045

  9 in total
  4 in total

1.  Antiobesity Activity of Two Polyherbal Formulations in High-Fat Diet-Induced Obese C57BL/6J Mice.

Authors:  Prakash Raj Pandeya; Gopal Lamichhane; Ramakanta Lamichhane; Jiao Luo; Xiao-Jun Li; Su-Jin Rhee; Liu Xiangqian; Hyun-Ju Jung
Journal:  Biomed Res Int       Date:  2022-05-11       Impact factor: 3.246

2.  Transcriptome of visceral adipose tissue identifies an inflammation-related ceRNA network that regulates obesity.

Authors:  Ganbin Li; Haoyu Zhang; Ke Cao; Zhiwei Zhai; Zhenjun Wang; Lei Yang; Jiagang Han
Journal:  Mol Cell Biochem       Date:  2022-01-22       Impact factor: 3.396

3.  Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission.

Authors:  Hao Zhou; Shuyi Wang; Pingjun Zhu; Shunying Hu; Yundai Chen; Jun Ren
Journal:  Redox Biol       Date:  2017-12-30       Impact factor: 11.799

4.  Switching from a high-fat cellulose diet to a high-fat pectin diet reverses certain obesity-related morbidities.

Authors:  Julie K Bray; Gabriel S Chiu; Leslie K McNeil; Morgan L Moon; Robyn Wall; Albert E Towers; Gregory G Freund
Journal:  Nutr Metab (Lond)       Date:  2018-08-06       Impact factor: 4.169

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.